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infarcted myocardium, as was first proposed in Chugh’s hypothesis
(6).
An important relevant observation is that the study population
had a mean duration of occlusion of the CTO vessel of 12  20
months. This study is therefore more likely to be able to answer the
often asked question about the role of angiographic collaterals in
predicting myocardial viability. This is because it is believed that
CTOs such as these give adequate time for collateral development,
unlike the recent occlusions studied using contrast echocardiogra-
phy soon after acute MI (7).
S.K. Chugh, MD
Interventional Cardiology
St. Paul’s Hospital
1081 Burrard Street
Room 5029
Vancouver, BC V62 1Y6
Canada
E-mail: drskchugh@hotmail.com
PII S0735-1097(02)01815-6
REFERENCES
1. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and
long-term survival among patients undergoing percutaneous coronary
intervention of a chronic total occlusion in native coronary arteries: a
20-year experience. J Am Coll Cardiol 2001;38:409–14.
2. Bolognese L, Cerisano CP, Bnonamici PV, et al. Influence of infarct
zone viability on left ventricular remodelling after acute myocardial
infarction. Circulation 1997;96:3353–9.
3. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography
predicts long-term survival after revascularization in patients with
ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848–54.
4. Buller CE, Dzavik V, Carere RG, et al. Primary stenting versus balloon
angioplasty in occluded coronary arteries: The Total Occlusion Study of
Canada (TOSCA). Circulation 1999;100:236–42.
5. Lee CW, Park SW, Cho GY, et al. Pressure-derived fractional
collateral blood flow: a primary determinant of left ventricular recovery
after reperfused myocardial infarction. J Am Coll Cardiol 2000;35:949–
55.
6. Chugh SK, Werner GS, Richartz BM, et al. Collateral flow index: to
assess myocardial viability—Chugh’s hypothesis revisited. Circulation
2001;104:13–E74.
7. Karila-Cohen D, Czitrom D, Brochet E, et al. Decreased no-reflow in
patients with anterior myocardial infarction and pre-infarction angina.
Eur Heart J 1999;20:1724–30.
REPLY
Dr. Chugh’s comments regarding our chronic total occlusion
(CTO) experience are well stated and germane to our findings.
Our intent for this project was to investigate the association
between long-term survival and successful recannulization of a
CTO. In order to demonstrate this association, a matched cohort
was developed using a propensity-scoring model. Thus, the com-
parison groups were remarkably similar with respect to baseline
covariates that are known predictors of long-term survival. In fact,
the survival curves for the matched cohort and the CTO group
were markedly similar. Only those patients with a successful
recannulization of a CTO demonstrated a survival benefit. This
link persisted following multivariate adjustment and was identified
in the failed percutaneous coronary intervention (PCI) cohort in
whom successful surgical recannulization of the CTO was per-
formed.
In our opinion, this body of work clearly identifies a group of
patients in whom successful PCI is associated with improved
long-term survival. There is no question that further work needs to
be performed on the mechanism of survival. Two leading theories
are certainly collateral flow and viability. Other plausible explana-
tions that are worthy of future investigation include the effect of
successful recannulization upon the incidence of sudden cardiac
death, left ventricular remodeling, and identification of certain
clinical patient subsets that are associated with an improved
survival following CTO and recannulization. For example, patients
with a history of diabetes mellitus have been demonstrated to have
a decreased incidence of collateral vessel formation despite abnor-
mal coronary atherosclerosis. However, patients with a history of
diabetes mellitus derived substantial benefit from a successful
recannulization of a chronic total occlusion in our study (data not
shown). To further our understanding of this cohort, we have
identified 558 patients from our nuclear database with a peri-
procedural radionucleotide perfusion study. We are hopeful that
this additional information will result in an enhanced understand-
ing of the survival benefit of successful recanalization of a CTO.
Finally, Dr. Chugh’s comments are insightful and, it is hoped,
will prompt future investigation into the mechanism of survival
benefit associated with a successful recannulization of a CTO.
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Is a High Hematocrit Level
Good for Patients With Heart Failure?
We were interested to read the article by Al-Ahmad and colleagues
(1) regarding the prognostic value of impaired renal function and
anemia in patients with left ventricular (LV) dysfunction, pub-
lished in the Journal of the American College of Cardiology. The
investigators report that reduced kidney function and a low
hematocrit are independent risk factors for increased all-cause
mortality in patients with LV dysfunction, with there being a
synergistic relationship between the two parameters. The results
from this study, together with other work in the field (2), may have
important clinical implications for the management of patients
with chronic heart failure (CHF). However, we believe several
points deserve further consideration.
The prognostic benefits of treating anemia in CHF and whether
there is an optimal range of hematocrit for survival are not known.
In the Framingham study, the impact of hematocrit on all-cause
death as well as morbidity and mortality due to cardiovascular
disease was shown to follow a U-shaped curve (3). Other prospec-
tive epidemiological studies of healthy populations have shown
that the lowest mortality rate correlates with a mid-range hemat-
ocrit level in both genders and at all ages (4). Al-Ahmad et al. (1)
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